The biological drug market is one of the fastest growing sectors of the pharmaceutical industry which corresponds to over 15% of the total pharmaceutical market. However, due to the patent expiry of many drugs, and increasing pressure from government, insurers and patient advocacy groups to reduce expenditure a number of opportunities for biosimilars have been created.

The biosimilars market is currently highly fragmented with many favorable circumstances for new or potential market entrants. With conducive regulatory developments, the biosimilars sector should pick up significantly; forming an important developing pharma market. With the new bills being passed, this is the time for progress.

For more information go to http://www.bharatbook.com/Market-Research-Reports/Conference-on-5th-Annual-Biosimilars-Conference-and-Workshop.html